Anti-inflammatory Reliever (AIR)

1 article · search the full text for this term

• Published Subscription Review Article 27 Jun 2026

  The Evolution of Asthma Management: A Comprehensive Analysis of GINA 2024 Guidelines, Endotype-Driven Diagnosis, and Targeted Biologic Intervention

  By Kuldeep Kate, Gopal Lohiya, Kranti Satpute, Prakash Honrao, Aniket Salunke, Yogesh Chavan

  Abstract: Asthma remains a substantial global public health challenge, characterized by heterogeneous airway inflammation leading to variable airflow obstruction. Recent advances in personalized medicine and guideline revisions, notably the Global Initiative for Asthma (GINA) 2024 update, mandate a profound paradigm shift from reliance on short-acting beta2-agonists (SABA) to antiinflammatory reliever (AIR) strategies utilizing inhaled corticosteroid (ICS)-formoterol. This report provides an exhaustive analysis of current asthma epidemiology, molecular pathogenesis distinguishing between Type …

  Published in Recent Trends in Infectious Diseases · Vol. 3, Issue 2, 2026 Read article →